Press Releases
2005
 
 
   

Press Release's for 2005

   
Date Title

December 16, 2005 BioMS Medical Announces Adoption of Shareholder Rights Plan

December 6, 2005 BioMS Receives 38 Additional Patents For Multiple Sclerosis Drug MBP8298

November 28, 2005 BioMS will Present at the Informed Investors Biotechnology & Healthcare Investor Forum

November 17, 2005 BioMS Announces Appointments to Board of Directors

November 14, 2005 BioMS Medical Announces Third Quarter 2005 Results

November 11, 2005 The MS Society of Canada, Alberta Division, Recognizes the MS Patient Care and Research Clinic at the University of Alberta

November 3, 2005 BioMS to Present at Rodman & Renshaw Healthcare Conference

October 27, 2005 Data Safety Monitoring Board Gives Positive Review for BioMS Medical's Pivotal MS Trial

October 3, 2005 BioMS Medical to Present at Biocontact 2005

September 29, 2005 BioMS to Present at Sachs-Bloomberg Investor Forum in Zurich

September 12, 2005 BioMS Announces Lead Investigator In Sweden For MS Trial

August 24, 2005 Webcast Alert: BioMS Medical Corp. Presentation at Informed Investors Biotechnology Forum

August 23, 2005 BioMS Medical Receives Approval to Extend Pivotal Multiple Sclerosis Trial Into Sweden

August 18, 2005 BioMS Pivotal MS Trial Receives Positive Safety Review From Data Safety Monitoring Board

August 12, 2005 BioMS Medical Announces Second Quarter 2005 Results

July 21, 2005 BioMS Medical Commences U.K. Patient Enrollment in Multiple Sclerosis Trial

June 16, 2005 BioMS Medical to Present at BIO 2005 in Philadelphia

May 31, 2005 BioMS Medical Announces U.K. Lead Investigator for MS Trial

May 20, 2005 BioMS Announces its Intention to Increase its Normal Course Issuer Bid

May 17, 2005 BioMS Medical Updates University of Alberta Equity Position

May 13, 2005 BioMS Medical Announces First Quarter 2005 Results

April 21, 2005 BioMS Provides Update For Pivotal MS Trial

March 23, 2005 BioMS Medical Raises $41.4 Million in Share Offering

February 18, 2005 BioMS Medical Announces 2004 Year-end Results

February 14, 2005 BioMS Medical Announces Short-Form Prospectus Offering for $36 Million

   
 
 
 
 
 
Copyright BioMS Medical 2008